Carbidopa Monohydrate is a pharmaceutical compound used as an active pharmaceutical ingredient in combination with levodopa for the management of symptoms associated with Parkinson's disease. It is supplied as a hydrate, salt-like form with specific stereochemistry, and is characterized by its aromatic ring and polar functional groups.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 38821-49-7
Carbidopa
active pharmaceutical ingredient
Carbidopa
active pharmaceutical ingredient
(R)-(+)-1-Phenylethylamine
pharmaceutical intermediate
Glucosamine sulfate sodium chloride
active pharmaceutical ingredient
Nalidixic acid
quinolone antibiotic active pharmaceutical ingredient
Cyclic Somatostatin
active pharmaceutical ingredient
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid;hydrate
QTAOMKOIBXZKND-PPHPATTJSA-N
C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.O